PM
PROF

Penbrook Management’s Profound Medical PROF Stock Holding History

Penbrook Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.7K Buy
+12,300
New +$85K 0.06% 92

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Penbrook Management's PROF Position: Q1 2026 in Review

Penbrook Management opened a new position in Profound Medical (PROF) in Q1 2026: 12,300 shares worth $79.7K. The stake represents 0.06% of the portfolio and ranks #92 among its holdings.

57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Penbrook Management held 12,300 shares of Profound Medical worth $79.7K as of Q1 2026.
  • Profound Medical was a new Penbrook Management position in Q1 2026.
  • Profound Medical made up 0.06% of Penbrook Management's portfolio in Q1 2026, its #92 holding.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Penbrook Management's 13F filing for Q1 2026, filed 21 Apr 2026.